IP Library › Patent Application 13751672
Patent Application
App. No. 13/751,672

Thiazolidinedione analogues

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/751,672
Abstract

The present invention relates to thiazolidinedione analogues that are useful for treating metabolic inflammation mediated diseases such as diabetes.

Claims (3)

1 . A method of treating dyslipidemia comprising administering to a patient a pharmaceutical composition comprising Compound No. 1:

or a pharmaceutically acceptable salt thereof.

20 - 26 . (canceled)

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded May 19, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 038652/0097 →
SECURITY INTEREST Recorded May 3, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: ALZHEIMER DRUG DISCOVERY FOUNDATION
Reel/Frame 038447/0317 →
SECURITY AGREEMENT Recorded Feb 5, 2014
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: SQUARE 1 BANK
Reel/Frame 032162/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2013
From: COLCA, GERARD R.; KLETZIEN, ROLF F.
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 030039/0078 →